XML 35 R21.htm IDEA: XBRL DOCUMENT v3.25.3

Composition of Certain Consolidated Financial Statement Line Items (Tables)

9 Months Ended

Sep. 30, 2025

Composition of Certain Consolidated Financial Statement Line Items

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​
​	​	SEPTEMBER 30,		​	DECEMBER 31,		​
​		2025			2024
Accrued compensation	​	$	8,551	​	$	7,290	​
Accrued research and development expenses	​		5,192	​		5,460	​
Accrued clinical expenses	​	​	13,493	​	​	7,025	​
Accrued professional services	​	​	3,122	​	​	2,918	​
Accrued other liabilities	​		6,571	​		3,606	​
Total accrued expenses and other current liabilities	​	$	36,929	​	$	26,299	​
​	​	​	​	​	​	​	​

​

X

- Definition

Tabular disclosure of accrued expenses and other current liabilities.

+ References

No definition available.

+ Details

Name:	gpcr_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock
Namespace Prefix:	gpcr_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	srt_ItemsIncludedInConsolidatedStatementOfFinancialConditionAbstract
Namespace Prefix:	srt_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration